跳至主要内容
临床试验/NCT03097536
NCT03097536终止不适用

Migraine and Homeostasis:What Can we Learn From Glucose

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
30
试验地点
2
主要终点
The difference in blood glucose on days with migraine compared to blood glucose on days without migraine

研究概览

简要总结

Patients with migraine often report that stressors such as skipping a meal can bring on a migraine whereas some patients report that their migraine improves with food. Few studies to date have looked at the relationship between blood glucose (sugar) and migraine. We are conducting this study to better understand whether or not changes in blood glucose levels can trigger migraine or provide relief during a migraine attack.

详细描述

The purpose of this pilot and feasibility study is to assess if changes in blood glucose both trigger migraine and can provide analgesia. This information will provide a vital basis for the mechanism of migraine and offer insights into better treatments as well as prevention.

This is a pilot unblinded randomized trial with two independent components, Aims 1 and 2. It is not possible to blind the current protocol both in terms of the blood sugar readings and the luna bar, non-luna bar intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female participants, age 18-65 with episodic migraine with or without aura (ICHD-II) and/or morning onset and/or patients who self identify that eating reduces their migraine intensity.

排除标准

  • Chronic migraine, use of hypoglycemic medication, DM I or II, abnormal finger stick glucose, obesity, comorbid eating disorders, pregnancy, seizure disorder, other serious mental or physical condition that would impair participation in the study

结局指标

主要结局

The difference in blood glucose on days with migraine compared to blood glucose on days without migraine

时间窗: Change Measure: migraine days and non-migraine days over 3 month period.

The primary endpoint will be the difference in blood glucose on days with migraine compared to blood glucose on days without migraine using repeated measure ANOVA

次要结局

  • The primary outcome is the change in pain score from the time of pain plateau to the pain score at 120 minutes as measured by a visual analogue scale.(Change Measure: migraine days and non-migraine days over 3 month period.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexandra Hovaguimian

Instructor in Neurology

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验

Migraine and Homeostasis:What Can we Learn From... | 临床试验